Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease - PubMed (original) (raw)
Review
Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease
Elaine M Castilow et al. Immunol Res. 2007.
Abstract
Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection in infants and children worldwide. In addition, RSV causes serious disease in elderly and immune compromised individuals. RSV infection of children previously immunized with a formalin-inactivated (FI)-RSV vaccine is associated with enhanced disease and pulmonary eosinophilia that is believed to be due to an exaggerated memory Th2 response. As a consequence, there is currently no licensed RSV vaccine and detailed studies directed towards prevention of vaccine-associated disease are a critical first step in the development of a safe and effective vaccine. The BALB/c mouse model of RSV infection faithfully mimics the human respiratory disease. Mice previously immunized with either FI-RSV or a recombinant vaccinia virus (vv) that expresses the attachment (G) glycoprotein exhibit extensive lung inflammation and injury, pulmonary eosinophilia, and enhanced disease following challenge RSV infection. CD4 T cells secreting Th2 cytokines are necessary for this response because their depletion eliminates eosinophilia. Intriguing recent studies have demonstrated that RSV-specific CD8 T cells can inhibit Th2-mediated pulmonary eosinophilia in vvG-primed mice by as yet unknown mechanisms. Information gained from the animal models will provide important information and novel approaches for the rational design of a safe and efficacious RSV vaccine.
Similar articles
- The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.
Olson MR, Hartwig SM, Varga SM. Olson MR, et al. J Immunol. 2008 Dec 1;181(11):7958-68. doi: 10.4049/jimmunol.181.11.7958. J Immunol. 2008. PMID: 19017987 Free PMC article. - CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.
Olson MR, Varga SM. Olson MR, et al. J Immunol. 2007 Oct 15;179(8):5415-24. doi: 10.4049/jimmunol.179.8.5415. J Immunol. 2007. PMID: 17911628 - Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease.
Stevens WW, Sun J, Castillo JP, Braciale TJ. Stevens WW, et al. Viral Immunol. 2009 Jul;22(4):243-51. doi: 10.1089/vim.2009.0016. Viral Immunol. 2009. PMID: 19594395 Free PMC article. - Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
Johnson TR, Graham BS. Johnson TR, et al. Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S46-57. doi: 10.1097/01.inf.0000108192.94692.d2. Pediatr Infect Dis J. 2004. PMID: 14730270 Review. - The CD4 T cell response to respiratory syncytial virus infection.
Christiaansen AF, Knudson CJ, Weiss KA, Varga SM. Christiaansen AF, et al. Immunol Res. 2014 Aug;59(1-3):109-17. doi: 10.1007/s12026-014-8540-1. Immunol Res. 2014. PMID: 24838148 Review.
Cited by
- Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus.
Dillard JA, Taft-Benz SA, Knight AC, Anderson EJ, Pressey KD, Parotti B, Martinez SA, Diaz JL, Sarkar S, Madden EA, De la Cruz G, Adams LE, Dinnon KH 3rd, Leist SR, Martinez DR, Schäfer A, Powers JM, Yount BL Jr, Castillo IN, Morales NL, Burdick J, Evangelista MKD, Ralph LM, Pankow NC, Linnertz CL, Lakshmanane P, Montgomery SA, Ferris MT, Baric RS, Baxter VK, Heise MT. Dillard JA, et al. Nat Commun. 2024 May 3;15(1):3738. doi: 10.1038/s41467-024-47450-x. Nat Commun. 2024. PMID: 38702297 Free PMC article. - Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias.
Eberlein V, Rosencrantz S, Finkensieper J, Besecke JK, Mansuroglu Y, Kamp JC, Lange F, Dressman J, Schopf S, Hesse C, Thoma M, Fertey J, Ulbert S, Grunwald T. Eberlein V, et al. Front Immunol. 2024 Apr 5;15:1382318. doi: 10.3389/fimmu.2024.1382318. eCollection 2024. Front Immunol. 2024. PMID: 38646538 Free PMC article. - Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus.
Shao S, Zhang XF, Hou JW, Yang SS, Han ZB, Wu HL, Tang F, Li XY, Lei ZH, Zhao ZX, Li SX, Liu ZM, Shan P, Jin YQ, Su JG, Liang Y, Zhang J, Li QM. Shao S, et al. NPJ Vaccines. 2024 Mar 19;9(1):62. doi: 10.1038/s41541-024-00855-7. NPJ Vaccines. 2024. PMID: 38503757 Free PMC article. - Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus.
Heise M, Dillard J, Taft-Benz S, Knight A, Anderson E, Pressey K, Parotti B, Martinez S, Diaz J, Sarkar S, Madden E, De la Cruz G, Adams L, Dinnon K 3rd, Leist S, Martinez D, Schaefer A, Powers J, Yount B, Castillo I, Morales N, Burdick J, Evangelista MK, Ralph L, Pankow N, Linnertz C, Lakshmanane P, Montgomery S, Ferris M, Baric R, Baxter V. Heise M, et al. Res Sq [Preprint]. 2023 Oct 27:rs.3.rs-3401539. doi: 10.21203/rs.3.rs-3401539/v1. Res Sq. 2023. PMID: 37961507 Free PMC article. Updated. Preprint. - Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model.
Eberlein V, Ahrends M, Bayer L, Finkensieper J, Besecke JK, Mansuroglu Y, Standfest B, Lange F, Schopf S, Thoma M, Dressman J, Hesse C, Ulbert S, Grunwald T. Eberlein V, et al. Viruses. 2023 Aug 30;15(9):1846. doi: 10.3390/v15091846. Viruses. 2023. PMID: 37766253 Free PMC article.
References
- J Virol. 2007 Mar;81(5):2349-58 - PubMed
- J Virol. 2004 Aug;78(16):8753-60 - PubMed
- Allergy. 2004 Aug;59(8):793-805 - PubMed
- J Virol. 1995 Feb;69(2):1261-4 - PubMed
- Immunology. 2006 Apr;117(4):433-42 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials